Nolato AB (publ) (STO:NOLA.B)
Sweden · Delayed Price · Currency is SEK 51.70
+0.70 (1.37%)
Aug 14, 2026, 5:29 PM CET
Nolato AB Market Cap
Nolato AB has a market cap or net worth of 13.93 billion as of August 14, 2026. Its market cap has decreased by -9.38% in one year.
Market Cap
13.93B
Enterprise Value
15.21B
Revenue
9.43B
Ranking
n/a
PE Ratio
19.51
Stock Price
51.70
ChartMarket Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 660.32M to 13.93B, an increase of 2,009.12%. That is a compound annual growth rate of 10.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 13.93B | -16.34% |
| Dec 30, 2025 | 16.65B | 14.02% |
| Dec 30, 2024 | 14.60B | 2.46% |
| Dec 29, 2023 | 14.25B | -3.20% |
| Dec 30, 2022 | 14.72B | -49.35% |
| Dec 30, 2021 | 29.07B | 30.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 65.40B |
| Sectra AB | 54.56B |
| Elekta AB | 20.56B |
| Vitrolife AB | 12.32B |
| Xvivo Perfusion AB | 9.30B |
| MedCap AB | 8.25B |
| CellaVision AB | 3.64B |
| C-Rad AB | 1.22B |